Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells

BACKGROUND: Resistance of cholangiocarcinoma to chemotherapy is a major problem in cancer treatment. The mechanism of resistance is believed to involve phosphoinositide-3- kinase (PI3K)/Akt activation. Although the platinum-containing compound oxaliplatin has been extensively used in the treatment o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Leelawat, Kawin, Narong, Siriluck, Udomchaiprasertkul, Wandee, Leelawat, Surang, Tungpradubkul, Sumalee
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Primary Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2628866/
https://ncbi.nlm.nih.gov/pubmed/19128511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-9-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller